Evidence map›Paper›PMID 31827530›Full record

ArticleStem cells international2019

CTGF Attenuates Tendon-Derived Stem/Progenitor Cell Aging.

Yun-Feng Rui, Min-Hao Chen, Ying-Juan Li, Long-Fei Xiao, Peng Geng, Pei Wang, Zheng-Yuan Xu, Xuan-Pu Zhang, Guang-Chun Dai

Open access · goldAbstract read
In one paragraph

Article in Stem cells international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Viable tendon neotissue from adult adipose-derived multipotent stromal cells.Frontiers in bioengineering and biotechnology · 2023
    Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yun-Feng RuiDepartment of Orthopaedics, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.ORCID https://orcid.org/0000-0001-9019-5531
Min-Hao ChenDepartment of Orthopaedics, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.ORCID https://orcid.org/0000-0001-9074-7076
Ying-Juan LiChina Orthopedic Regenerative Medicine Group, Hangzhou, Zhejiang 310000, China.ORCID https://orcid.org/0000-0002-5580-1003
Long-Fei XiaoDepartment of Orthopaedics, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.ORCID https://orcid.org/0000-0002-6251-9161
Peng GengDepartment of Orthopaedics, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.ORCID https://orcid.org/0000-0002-3492-0580
Pei WangSchool of Medicine, Southeast University, Nanjing, China.ORCID https://orcid.org/0000-0002-1968-5973
Zheng-Yuan XuSchool of Medicine, Southeast University, Nanjing, China.ORCID https://orcid.org/0000-0002-5151-9262
Xuan-Pu ZhangSchool of Medicine, Southeast University, Nanjing, China.ORCID https://orcid.org/0000-0001-7268-7428
Guang-Chun DaiDepartment of Orthopaedics, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.ORCID https://orcid.org/0000-0003-1440-4850
Zhongda Hospital Southeast University · CNSoutheast University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aged tendon-derived stem/progenitor cells (TSPCs) lead to age-related tendon disorders and impair tendon healing. However, the underlying molecular mechanisms of TSPC aging remain largely unknown. Here, we investigated the role of connective tissue growth factor (CTGF) in TSPC aging. CTGF protein and mRNA levels were markedly decreased in the aged TSPCs. Moreover, recombinant CTGF attenuates TSPC aging and restores the age-associated reduction of self-renewal and differentiation of TSPCs. In addition, cell cycle distribution of aged TSPCs was arrested in the G1/S phase while recombinant CTGF treatment promoted G1/S transition. Recombinant CTGF also rescued decreased levels of cyclin D1 and CDK4 and reduced p27

Identifiers

PMID31827530
PMCPMC6881574
OpenAlexW2986037217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.